IL1B and neuropathy: For example, administration of antibodies to interleukin I-receptor (IL-lR) or its genetic deletion or overexpression of interleukin receptor antagonist (IL-RA) reduce pain behavior in mice with experimental neuropathy thereby implicating IL-1β in the onset of neuropathic pain (2, 54, 57, 58, 202).